P-360: Sustained continuous glucose monitoring engagement and glycemic improvement in a predominantly young socioeconomically vulnerable type 1 diabetes population
P-360: Anhaltendes Engagement bei kontinuierlichem Glukosemonitoring und glykämische Verbesserung in einer überwiegend jungen, sozioökonomisch vulnerablen Population mit Typ-1-Diabetes
Hormone Research in Paediatrics · 04.11.2026 · 99 (Supplement_4)
DOI: 10.1159/hrp/adaag020.418 ↗Auf einen Blick
Bei 53 Personen mit Typ-1-Diabetes in einer öffentlichen Klinik in Nordostbrasilien gingen HbA1c und andere glykämische Parameter unter intermittierend gescanntem CGM zurück. Die Nutzung blieb über 6 Monate hoch.
Fragestellung
Welche glykämischen Ergebnisse und welches Nutzungsverhalten zeigen sich unter CGM in einer überwiegend jungen Population mit Typ-1-Diabetes aus einem öffentlichen Versorgungssetting?
Methode
6-monatige longitudinale Studie mit 53 Personen mit Typ-1-Diabetes; intermittierend gescanntes CGM; HbA1c zu Studienbeginn und nach 6 Monaten, monatliche CGM-Berichte und Fragebögen.
Ergebnisse
32 (60,4 %) waren unter 25 Jahren. HbA1c sank von 9,7±1,19 % auf 7,9±1,86 %; bei unter 25-Jährigen von 9,08±1,92 % auf 8,37±1,83 %. Sensoraktivzeit 80,7 %, Time in range 48,5 %, GMI 7,6 %.
Schlussfolgerung der Autor:innen
CGM war mit glykämischer Verbesserung und anhaltendem Engagement in einer vulnerablen Population überwiegend junger Menschen mit Typ-1-Diabetes verbunden und unterstreicht den Bedarf an fairen Zugangsregeln im öffentlichen Gesundheitswesen.
Kernaussagen
- HbA1c sank über 6 Monate unter CGM
- Sensoraktivzeit 80,7 %; nächtliches Monitoring 95,9 %
- Autonomie beim Scannen stieg von 28,3 % auf 52,1 %
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Hormone Research in Paediatrics, online erschienen am 04.11.2026. Verfasst von G L Torres und 10 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
Continuous glucose monitoring (CGM) improves glycemic control in type 1 diabetes (T1D), yet evidence from public health settings in socioeconomically vulnerable young populations remains scarce.
Objectives
To evaluate glycemic outcomes and user engagement with CGM in a predominantly young T1D population followed at a public health clinic in Northeastern Brazil.
Methods
A 6-month longitudinal study enrolled 53 individuals with T1D. An intermittently scanned CGM device was used throughout follow-up. Glycated hemoglobin (HbA1c) was measured at baseline and at six months. Monthly CGM reports and questionnaires captured glycemic metrics and user behavior.
Results
A total of 32 (60.4%) of participants were under 25 years of age. The cohort was mostly self-declared Black or mixed-race (81.1%), with income up to 2 minimum wages (77.4%). HbA1c decreased from 9.7±1.19% to 7.9±1.86% over six months. In the under-25 group, baseline HbA1c was 9.08±1.92%, decreasing to 8.37±1.83% at six months. Across the full cohort, sensor active time was 80.7%, time in range 48.5%, and glucose management indicator 7.6%. Daily scans averaged 8.7, with near-universal nocturnal monitoring (95.9%). Median daily scan frequency differed across age groups: 6.6 in children under 12, 14.9 in adolescents, and 17.2 in adults aged 18-25 years. Most participants (77%) used CGM data to prevent hypoglycemia and 60.4% reported no discrepancy with capillary glucose at six months. Autonomy in scanning rose from 28.3% to 52.1%. Dermatitis was observed in approximately 15% of participants. A high-engagement group (active time equal to or above 70% and 8 or more scans/day) comprised 30.2% of participants.
Conclusions
Continuous glucose monitoring promoted glycemic improvement and sustained engagement in a vulnerable population of predominantly young individuals with T1D, reinforcing the need for equitable access policies in public health systems.
Zitieren
APA
Torres, G. L., Lima, L. P. S., Lemos, S. D. S. F., Freitas, J. P. A., Monteiro, N. C., Machado, M. D. L. P., Martins, L. M., Varela, M. G., Trevisan, T., Santana, N. O. D., & FUS (2026). P-360: Sustained continuous glucose monitoring engagement and glycemic improvement in a predominantly young socioeconomically vulnerable type 1 diabetes population. Hormone Research in Paediatrics, 99(Supplement_4). https://doi.org/10.1159/hrp/adaag020.418
Vancouver
Torres GL, Lima LPS, Lemos SDSF, Freitas JPA, Monteiro NC, Machado MDLP, et al. P-360: Sustained continuous glucose monitoring engagement and glycemic improvement in a predominantly young socioeconomically vulnerable type 1 diabetes population. Hormone Research in Paediatrics. 2026;99(Supplement_4). doi:10.1159/hrp/adaag020.418
BibTeX
@article{Torres2026,
author = {Torres, G L and Lima, L P S and Lemos, S d S F and Freitas, J P A and Monteiro, N C and Machado, M d L P and Martins, L M and Varela, M G and Trevisan, T and Santana, N O d and FUS},
title = {P-360: Sustained continuous glucose monitoring engagement and glycemic improvement in a predominantly young socioeconomically vulnerable type 1 diabetes population},
journal = {Hormone Research in Paediatrics},
year = {2026},
volume = {99},
number = {Supplement_4},
doi = {10.1159/hrp/adaag020.418}
}
EUVIMED